SPHK1 and neoplasm: SPHK in tumor cells may not be a promising treatment target for cancer, because novel, highly potent, and selective SPHK inhibitors that reduced S1P to undetectable levels in tumor cells did not affect their growth in vivo or in vitro53–55.